PD-1 expression and clinical PD-1 blockade in B-cell lymphomas von Xu-Monette, Zijun Y., Zhou, Jianfeng, Young, Ken H.

Volltext

Diffuse large B-cell lymphoma von Li, Shaoying, Young, Ken H., Medeiros, L. Jeffrey

Volltext

Checkpoint inhibitors in hematological malignancies von Ok, Chi Young, Young, Ken H

Volltext

New agents and regimens for diffuse large B cell lymphoma von Wang, Liang, Li, Lin-rong, Young, Ken H.

Volltext

PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response? von Xu-Monette, Zijun Y, Zhang, Mingzhi, Li, Jianyong, Young, Ken H

Volltext

RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics von Pandey, Poonam R, Young, Ken H, Kumar, Dhiraj, Jain, Neeraj

Volltext

Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemia von Young, Ken H.

Volltext

Hematopoietic stem cell transplantation for adults with T-cell lymphoblastic lymphoma: can we successfully step into the era of precision medicine? von Young, Ken H.

Volltext

Genetic alterations and their clinical implications in DLBCL von Miao, Yi, Medeiros, L. Jeffrey, Li, Yong, Li, Jianyong, Young, Ken H.

Volltext

EBV-positive diffuse large B-cell lymphoma of the elderly von Ok, Chi Young, Papathomas, Thomas G., Medeiros, L. Jeffrey, Young, Ken H.

Volltext

Digital breast tomosynthesis (DBT): a review of the evidence for use as a screening tool von Gilbert, Fiona J, Tucker, Lorraine, Young, Ken C

Volltext

CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1-positive B-Cell Lymphoma von Liu, Hui, Lei, Wen, Zhang, Chaoting, Yang, Chunmei, Wei, Juying, Guo, Qunyi, Guo, Xiaojun, Chen, Zhilu, Lu, Ying, Young, Ken H., Lu, Zheming, Qian, Wenbin

Volltext

EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management von Ok, Chi Young, Li, Ling, Young, Ken H

Volltext

NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms von Yu, Li, Li, Ling, Medeiros, L. Jeffrey, Young, Ken H

Volltext

MYD88 L265P Mutation in Lymphoid Malignancies von Yu, Xinfang, Li, Wei, Deng, Qipan, Li, Ling, Hsi, Eric D, Young, Ken H, Zhang, Mingzhi, Li, Yong

Volltext

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vinc... von MARIE GREEN, Tina, YOUNG, Ken H, MØLLER PEDERSEN, Lars, BOE MØLLER, Michael, VISCO, Carlo, XU-MONETTE, Zijun Y, ORAZI, Attilio, GO, Ronald S, NIELSEN, Ole, GADEBERG, Ole V, MOURITS-ANDERSEN, Torben, FREDERIKSEN, Mikael

Volltext

Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances von Wu, Huanling, Medeiros, L. Jeffrey, Young, Ken H.

Volltext

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma von Zhang, Jun, Medeiros, L Jeffrey, Young, Ken H

Volltext

Targeting the Programmed Death-1 Pathway in Lymphoid Neoplasms von Ok, Chi Young, Young, Ken H

Volltext

Recent advances in genomics and therapeutics in mantle cell lymphoma von Lu, Tingxun, Zhang, Jie, McCracken, Jenna M, Young, Ken H

Volltext